BlackRock Investment Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $5K | Hold |
4,837
| – | – | ﹤0.01% | 3732 |
|
|
2016
Q3 | $5K | Hold |
4,837
| – | – | ﹤0.01% | 3738 |
|
|
2016
Q2 | $7K | Buy |
4,837
+1,358
| +39% | +$1.97K | ﹤0.01% | 3734 |
|
|
2016
Q1 | $5K | Hold |
3,479
| – | – | ﹤0.01% | 3788 |
|
|
2015
Q4 | $6K | Buy |
3,479
+383
| +12% | +$661 | ﹤0.01% | 3808 |
|
|
2015
Q3 | $7K | Hold |
3,096
| – | – | ﹤0.01% | 3804 |
|
|
2015
Q2 | $8K | Sell |
3,096
-51,129
| -94% | -$132K | ﹤0.01% | 3786 |
|
|
2015
Q1 | $182K | Buy |
54,225
+530
| +1% | +$1.78K | ﹤0.01% | 3222 |
|
|
2014
Q4 | $186K | Buy |
53,695
+282
| +0.5% | +$977 | ﹤0.01% | 3250 |
|
|
2014
Q3 | $269K | Buy |
53,413
+1,539
| +3% | +$7.75K | ﹤0.01% | 3186 |
|
|
2014
Q2 | $716K | Buy |
+51,874
| New | +$716K | ﹤0.01% | 2826 |
|